logo
ResearchBunny Logo
Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors

Medicine and Health

Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors

F. Wittlinger, B. C. Ogboo, et al.

This groundbreaking study unveiled a series of bivalent EGFR inhibitors, showcasing their remarkable ability to target both ATP and allosteric pockets with enhanced potency against drug-resistant mutants. Conducted by a dedicated team of researchers, their innovative linker design has opened new avenues in bivalent agent strategies, providing insights that may change the landscape of cancer treatment.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny